ANKDD1A and glioblastoma: In addition, ANKDD1A also decreased the half-life of HIF1α by upregulating FIH1, decreased glucose uptake and lactate production, inhibited glioma cell autophagy, and induced apoptosis in GBM cells under hypoxia.